Accessibility Menu

Roche Ag(XSWX) RO

Market CapCHF 291.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+1,781%
5 Year-12%
1 Year+31%
1 Month+1%
CHF 360.40
-1.53%
-5.60Today
Roche Ag last closing stock price
MetricPriceDate
Last closeCHF 360.402026-08-31
Roche Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.05%CHF 375.602026-08-24
1 month+0.5%CHF 358.602026-07-31
3 month+14.12%CHF 315.802026-06-02
Year to date+7.52%CHF 335.202025-12-30
1 year+31.44%CHF 274.202025-08-29
3 year+29.64%CHF 278.002023-09-01
5 year-12.27%CHF 410.802021-09-01
Since inception+1,780.62%CHF 19.461992-01-02

Roche Ag Financials at a Glance

Market Cap

CHF 291.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

CHF 15.33

P/E Ratio

23.61

Dividend

CHF 9.80

Beta (Volatility)

-0.01 (Low)

Price

CHF 360.40

Volume

105,894

Open

CHF 367.00

Previous Close

CHF 366.00

Daily Range

CHF 360.40 - CHF 367.40

52-Week Range

CHF 264.60 - CHF 383.00

Estimated Earnings Date

N/A

RO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Roche Ag

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Industry

Pharmaceuticals

Sector

Health Care

Employees

112,774

CEO

Thomas Schinecker, PhD

Website

www.roche.com

RO Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

40.22%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

4.24%

Dividend Yield

2.68%

Payout Ratio

N/A

Stock Overview

Market Cap

CHF 291.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

795.62M

Volume

105.89K

Avg. Volume

25.12K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Roche Ag Performance Analysis

Roche Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 63,281,000,0000.8%
20232023-12-31CHF 58,716,000,000-7.2%
20242024-12-31CHF 60,495,000,0003.0%
20252025-12-31CHF 61,516,000,0001.7%
Roche Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 15.53-4.1%
20232023-12-31CHF 14.30-7.9%
20242024-12-31CHF 10.32-27.8%
20252025-12-31CHF 16.0455.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

CHF 291.20BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PCGPG&E
$13.27-0.20%
NVDANvidia
$220.78+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.97+0.11%
CNHCNH Industrial
$11.83+0.01%

Questions About RO

What is the current price of Roche Ag?

Roche Ag is trading at CHF 360.40 per share.

What is the 52-week range for Roche Ag?

Over the past 52 weeks, Roche Ag has traded between CHF 264.60 and CHF 383.00.

How much debt does Roche Ag have?

As of the most recent reporting period, Roche Ag reported total debt of CHF 33.19B.

How much cash does Roche Ag have on hand?

Roche Ag reported CHF 5.58B in cash and cash equivalents in its most recent financial results.

What is Roche Ag’s dividend yield?

Roche Ag currently has a dividend yield of 2.68%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services